CHI3L1 and Hepatic fibrosis: Recklies et al. also showed that YKL-40 was preferentially expressed in areas with active fibrogenesis in patients with hepatic fibrosis, where it may act synergistically with insulin-like growth factor I to stimulate the growth of fibroblasts [14, 25].